February 9, 2016
Dublin-based medication adherence company HealthBeacon raised $1.13 million (1 million euros) in seed funding from the Irish government through Enterprise Ireland as well as private medical and technology angel investors.
The company’s offering is a sharps container that people who take injectable medications can use to discard their needles.
HealthBeacon cofounder Jim Joyce told MobiHealthNews...
January 18, 2016
UK-based Babylon, a remote care company, has raised $25 million in a round led by Investment AB Kinnevik with participation from Hoxton Ventures, Innocent Drinks cofounders Richard Reed, Adam Balon, and Jon Wright, as well as Deepmind cofounders Demis Hassabis and Mustafa Suleyman.
The company’s CEO and founder, Ali Parsa, began working on Babylon in 2013 and launched the offering in early 2105...
January 12, 2016
There are many approaches to using digital technology to promote medication adherence, from tiny sensors embedded in pills to Bluetooth-connected pill boxes, to simple reminder apps. There’s something of a trade-off between hardware offerings, which provide real validation and accountability but can be expensive to deploy and scale, and software offerings, which are very easy to scale, but have a...
January 11, 2016
Google has filed another interesting healthcare-related patent, a mechanism that could detect when a patient is eating and issue a contextual reminder to take a medication.
Israel-based patent authors Asaf Zomet and Michael Shynar describe the patented invention as one that uses some mechanism to detect when the user is eating, confirms that this is the case, and then delivers “a reminder to...
January 11, 2016
Redwood City, California-based Proteus Digital Health announced its first US healthcare provider customer, Barton Health, which will prescribe the company's Proteus Discover to patients. The company says this is the first time its technology has been implemented outside of a clinical trial setting in the US.
Barton Health, a health system in Lake Tahoe, California, will use the medication...
October 28, 2015
AdhereTech, the New York City-based smart pill bottle company, has begun shipping the generation 2 version of its bottle to pharma and provider customers. The new version incorporates a number of changes based on user feedback that make it more robust, easier to use, and expand the reach of the company outside the United States. AdhereTech raised $1.75 million to develop the new bottle last year...
July 27, 2015
AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma.
Adherium's Smartinhaler sends data on when medication was taken to mobile devices and desktop computers via Bluetooth. The platform is designed to help patients, caregivers,...
July 9, 2015
PillPack, the mail-order pharmacy that raised $50 million last June, has finally gone mobile, launching its first app, for iOS and Apple Watch. The PillPack app will be available to everyone, not just PillPack customers, and has several novel features for a medication reminder app.
“The best solution to adherence is simplicity, and the PillPack design tackles this challenge physically with our...
July 2, 2015
Proteus Digital Health has received an update to its FDA 510(k) clearance for its digital medicine platform, adding a new indication to the clearance. The system is now, to the company’s knowledge, the first technology to have an indication in its FDA clearance for measuring medication adherence.
“We are delighted that our collaborative work with the FDA continues to enable positive progress,”...
June 11, 2015
More than 70 percent of Walgreens Balance Rewards members participating in the healthy choices program with a connected device were still active in the program a year later, according to Walgreens. The retail pharmacy released data from a series of studies the company conducted in 2014, showing that their rewards program increased adherence to hypertension and diabetes medications.